MCID: FRG008
MIFTS: 33

Fragile X-Associated Tremor/ataxia Syndrome malady

Genetic diseases, Neuronal diseases, Rare diseases categories

Aliases & Classifications for Fragile X-Associated Tremor/ataxia Syndrome

About this section
Sources:
21Genetics Home Reference, 60UMLS, 9Disease Ontology, 20GeneTests, 47Orphanet, 26ICD10 via Orphanet, 61UMLS via Orphanet
See all sources

Fragile X-Associated Tremor/ataxia Syndrome, Aliases & Descriptions:

Name: Fragile X-Associated Tremor/ataxia Syndrome 9 20 21 47
Fragile X Tremor/ataxia Syndrome 21 60
 
Fxtas Syndrome 9 47
Fxtas 21


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases, Rare diseases
Anatomical: Neuronal diseases


Characteristics (Orphanet epidemiological data):

47
fragile x-associated tremor/ataxia syndrome:
Inheritance: X-linked dominant; Prevalence: 1-9/100000 (United States); Age of onset: Adult; Age of death: elderly


External Ids:

Disease Ontology9 DOID:0050879
Orphanet47 93256
ICD10 via Orphanet26 G11.2
UMLS via Orphanet61 C3164069

Summaries for Fragile X-Associated Tremor/ataxia Syndrome

About this section


Genetics Home Reference:21 Fragile X-associated tremor/ataxia syndrome (FXTAS) is characterized by problems with movement and thinking ability (cognition). FXTAS is a late-onset disorder, usually occurring after age 50, and its signs and symptoms worsen with age. This condition affects males more frequently and severely than females. Affected individuals have areas of damage in the part of the brain that controls movement (the cerebellum) and in a type of brain tissue known as white matter, which can be seen with magnetic resonance imaging (MRI). This damage leads to the movement problems and other impairments associated with FXTAS.

MalaCards based summary: Fragile X-Associated Tremor/ataxia Syndrome, also known as fragile x tremor/ataxia syndrome, is related to ataxia and tremor, and has symptoms including gait disturbance, tremor and cerebral cortical atrophy. An important gene associated with Fragile X-Associated Tremor/ataxia Syndrome is FMR1 (fragile X mental retardation 1). Affiliated tissues include cerebellum, brain and pons.

Disease Ontology:9 A neurodegenerative disease that is characterized by adult-onset progressive intention tremor and gait ataxia, has material basis in expanded trinucleotide repeat of the fmr1 gene that results in a toxic gain of function of fmr1 rna.

Related Diseases for Fragile X-Associated Tremor/ataxia Syndrome

About this section

Diseases related to Fragile X-Associated Tremor/ataxia Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 19)
idRelated DiseaseScoreTop Affiliating Genes
1ataxia11.4
2tremor11.4
3fragile x tremor/ataxia syndrome10.9
4fragile x syndrome10.8
5dementia10.8
6mental retardation10.7
7neuropathy10.7
8fragile x-associated primary ovarian insufficiency10.6
9blindness10.6
10multiple system atrophy10.4
11axonal neuropathy10.4
12choroiditis10.4
13mood disorder10.4
14myoclonus10.4
15huntington disease10.0
16cerebellar ataxia10.0
17sleep apnea10.0
18spastic paraparesis10.0
19spasticity10.0

Graphical network of diseases related to Fragile X-Associated Tremor/ataxia Syndrome:



Diseases related to fragile x-associated tremor/ataxia syndrome

Symptoms for Fragile X-Associated Tremor/ataxia Syndrome

About this section

Symptoms:

 47 (show all 29)
  • cortical atrophy without hydrocephaly/cerebral hemiatrophy/subcortical atrophy
  • abnormal gait
  • ataxia/incoordination/trouble of the equilibrium
  • tremor
  • execution movement disorder/dysmetria/bradykinesia/akinesia/apraxia
  • elocution disorders/dysarthria/dysphonia
  • psychic/psychomotor regression/dementia/intellectual decline
  • troubles of memory/amnesia/hypermnesia
  • x-linked dominant inheritance
  • fragile chromosome x site
  • pollakiuria/polyuria/dysuria/anuria/acute urine retention/oliguria
  • impotence/painful erection/priapism/erection troubles
  • cerebellum/cerebellar vermis anomaly/agenesis/hypoplasia
  • dysautonomia/autonomous nervous sytem anomalies
  • peripheral neuropathy
  • sphincter dysfunction
  • hypertonia/spasticity/rigidity/stiffness
  • areflexia/hyporeflexia
  • paresthesia/dysesthesia/hypoesthesia/anesthesia/numbness
  • obsessive-compulsive disorder
  • humour troubles/anxiety/depression/apathy/euphoria/irritability
  • muscle weakness/flaccidity
  • feeding disorder/dysphagia/swallowing/sucking disorder/esophageal dyskinesia
  • encopresis/fecal incontinence
  • chronic arterial hypertension
  • hypotension
  • hypothyroidy
  • midbrain/brainstem/pons/medulla anomalies
  • myalgia/muscular pain

HPO human phenotypes related to Fragile X-Associated Tremor/ataxia Syndrome:

(show all 22)
id Description Frequency HPO Source Accession
1 gait disturbance hallmark (90%) HP:0001288
2 tremor hallmark (90%) HP:0001337
3 cerebral cortical atrophy hallmark (90%) HP:0002120
4 neurological speech impairment hallmark (90%) HP:0002167
5 incoordination hallmark (90%) HP:0002311
6 memory impairment hallmark (90%) HP:0002354
7 developmental regression hallmark (90%) HP:0002376
8 obsessive-compulsive behavior typical (50%) HP:0000722
9 hypertonia typical (50%) HP:0001276
10 reduced tendon reflexes typical (50%) HP:0001315
11 muscle weakness typical (50%) HP:0001324
12 abnormality of the autonomic nervous system typical (50%) HP:0002270
13 paresthesia typical (50%) HP:0003401
14 aplasia/hypoplasia of the cerebellum typical (50%) HP:0007360
15 abnormal renal physiology typical (50%) HP:0012211
16 erectile abnormalities typical (50%) HP:0100639
17 hypothyroidism occasional (7.5%) HP:0000821
18 hypertension occasional (7.5%) HP:0000822
19 bowel incontinence occasional (7.5%) HP:0002607
20 hypotension occasional (7.5%) HP:0002615
21 myalgia occasional (7.5%) HP:0003326
22 feeding difficulties in infancy occasional (7.5%) HP:0008872

Drugs & Therapeutics for Fragile X-Associated Tremor/ataxia Syndrome

About this section

Drug clinical trials:

Search ClinicalTrials for Fragile X-Associated Tremor/ataxia Syndrome

Search NIH Clinical Center for Fragile X-Associated Tremor/ataxia Syndrome

Genetic Tests for Fragile X-Associated Tremor/ataxia Syndrome

About this section

Genetic tests related to Fragile X-Associated Tremor/ataxia Syndrome:

id Genetic test Affiliating Genes
1 Fragile X-Associated Tremor/ataxia Syndrome20 FMR1

Anatomical Context for Fragile X-Associated Tremor/ataxia Syndrome

About this section

MalaCards organs/tissues related to Fragile X-Associated Tremor/ataxia Syndrome:

31
Cerebellum, Brain, Pons, Pituitary, Adrenal gland, Testes, Hypothalamus

Animal Models for Fragile X-Associated Tremor/ataxia Syndrome or affiliated genes

About this section

Publications for Fragile X-Associated Tremor/ataxia Syndrome

About this section

Articles related to Fragile X-Associated Tremor/ataxia Syndrome:

(show top 50)    (show all 109)
idTitleAuthorsYear
1
Long-term outcome of deep brain stimulation in fragile X-associated tremor/ataxia syndrome. (25577024)
2015
2
Memantine Effects on Verbal Memory in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS): a Double-Blind Brain Potential Study. (24871547)
2014
3
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome. (25136376)
2014
4
Axonal neuropathy in female carriers of the fragile X premutation with fragile X-associated tremor ataxia syndrome. (25388402)
2014
5
FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor/ataxia syndrome. (25471011)
2014
6
Pure psychiatric presentation of Fragile X-associated tremor/ataxia syndrome. (23889896)
2013
7
Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. (22918986)
2013
8
MicroRNA expression profiling in blood from fragile X-associated tremor/ataxia syndrome patients. (23790110)
2013
9
Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome. (24332449)
2013
10
RNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndrome. (22459047)
2012
11
Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. (22161987)
2012
12
Fragile X-associated tremor/ataxia syndrome. (21827901)
2012
13
Treatment of fragile X-associated tremor/ataxia syndrome with unilateral deep brain stimulation. (22344717)
2012
14
Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome. (22009357)
2012
15
Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome. (23074671)
2011
16
Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. (21558427)
2011
17
FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. (21116185)
2011
18
Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome. (20410144)
2010
19
Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. (20841969)
2010
20
Fragile X-associated tremor/ataxia syndrome (FXTAS) with myoclonus. (20063436)
2010
21
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome. (20161676)
2009
22
Levetiracetam improves intention tremor in fragile x-associated tremor/ataxia syndrome. (19471185)
2009
23
Treatment of fragile-X-associated tremor/ataxia syndrome with deep brain stimulation. (18951504)
2009
24
Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS). (19070606)
2009
25
Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome. (19794313)
2009
26
MRI and SPECT of midbrain and striatal degeneration in fragile X-associated tremor/ataxia syndrome. (18080849)
2008
27
Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. (18472227)
2008
28
Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease. (18384046)
2008
29
Oculomotor abnormalities in a patient with fragile X-associated tremor/ataxia syndrome. (18329929)
2008
30
Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study. (18165971)
2008
31
CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. (19014369)
2008
32
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. (18686748)
2008
33
Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. (17166801)
2007
34
CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). (17427188)
2007
35
Fragile X-associated tremor/ataxia syndrome--an older face of the fragile X gene. (17279084)
2007
36
Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. (17591512)
2007
37
Fragile X-associated tremor/ataxia syndrome: intrafamilial variability and the size of the FMR1 premutation CGG repeat. (17290448)
2007
38
Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome. (17726686)
2007
39
Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. (17618523)
2007
40
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). (17724287)
2007
41
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). (16332642)
2006
42
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome. (16773616)
2006
43
Intrafamilial variability in fragile X-associated tremor/ataxia syndrome. (16124012)
2006
44
Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. (16426093)
2006
45
Fragile X-associated tremor/ataxia syndrome]. (15981162)
2005
46
FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy. (15956167)
2005
47
GRAND ROUNDS: an atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated tremor/ataxia syndrome. (16131344)
2005
48
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. (15065016)
2004
49
Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. (15060119)
2004
50
Fragile X-associated tremor/ataxia syndrome (FXTAS). (14994285)
2004

Variations for Fragile X-Associated Tremor/ataxia Syndrome

About this section

Expression for genes affiliated with Fragile X-Associated Tremor/ataxia Syndrome

About this section
Search GEO for disease gene expression data for Fragile X-Associated Tremor/ataxia Syndrome.

Pathways for genes affiliated with Fragile X-Associated Tremor/ataxia Syndrome

About this section

Compounds for genes affiliated with Fragile X-Associated Tremor/ataxia Syndrome

About this section

GO Terms for genes affiliated with Fragile X-Associated Tremor/ataxia Syndrome

About this section

Products for genes affiliated with Fragile X-Associated Tremor/ataxia Syndrome

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Fragile X-Associated Tremor/ataxia Syndrome

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet